2001-es idegen nyelvű publikációk

  • Ambrus, A., Banyai, I., Weiss M.S., Hilgenfeld, R., Keresztessy, Zs, Muszbek, L., Fésüs, L.: Calcium binding of transgutaminases: a 43Ca NMR study combined with surface polarity analysis J. Biomol. Struct. Dyn. 19: 59-74 (2001)
  • Katona, É., Ajzner, É., Tóth, K., Kárpáti, L., Muszbek, L.: Enzyme linked immunosorbent assay (ELISA) for he determination of blood coagulation factor XIII A-subunit in plasma and in cell lysate J. Immun. Meth. 258: 127-135 (2001)
  • Mátyus, L., Bene, L., Hársfalvi, J., Alvarez, M.V., González-Rodríguez, J., Jenei, A., Muszbek, L., Damjanovich S.: Organization of the glycoprotein (GP) IIb/IIIa heterodimer on resting human platelets studied by flow cytometric energy transfer J. Photochem. Photobiol. B: Biology 65: 47-58 (2001)
  • Sipka S, Szanto S, Szucs K, Kovacs I, Kiss E, Antal-Szalmas P, Lakos G, Aleksza M, Illes A, Gergely P, Szegedi G: Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus Journal of Rheumatology, 28., 2012-2017, 2001.
  • Sipka S, Szucs K, Szanto S, Kovacs I, Lakos G, Kiss E, Antal-Szalmas P, Szegedi G, Gergely P: Glucocorticosteroid dependent decrease in the activity of calcineurin in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases, 60., 380-384, 2001.
  • Antal-Szalmas P, I. Szöllősi, G. Lakos, E. Kiss, I. Csipo, A. Sümegi, S. Sipka, J.A.G. van Strijp, K.P.M. van Kessel, Gy. Szegedi: A novel flow cytometric assay to quantify soluble CD14 concentration in human serum. Cytometry, 45., 115-23, 2001.
  • Ulrichts H, Depraetere H, Harsfalvi J, Deckmyn H. Selection of phages that inhibit vWF interaction with collagen under both static and flow conditions. Thromb Haemost. 2001 Aug;86(2):630-5
  • Cauwenberghs N, Vanhoorelbeke K, Vauterin S, Westra DF, Romo G, Huizinga EG, Lopez JA, Berndt MC, Harsfalvi J, Deckmyn H. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalphareveals interaction between the leucine-rich repeat N-terminal and C-terminalflanking domains of glycoprotein Ibalpha. Blood. 2001 Aug 1;98(3):652-60.
  • Bonnefoy A, Harsfalvi J, Pfliegler G, Fauvel-Lafeve F, Legrand C.: The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI. Thromb Haemost. 2001 Mar;85(3):552-9.
  • Góth L., Rass P., Madarasi I.: A novel catalase mutation detected by PCR-SSCP, nucleotide sequencing and Western blot analyzes is responsible for the type C of  Hungarian acatalasemia. Electrophoresis 2001;22:49-51.
  • Góth L. A new type of inherited catalase deficiencies:Its characterization and comparison to  the Japanese and Swiss type of acatalasemia. Blood Cells, Molecules and Diseases 2001:24:512-517.
  • Góth L. Lenkey Á, Bigler NW. Blood catalase and diabetes in Hungary. Diabetes Care 2001, 10, 1839-40.
  • Góth L.  A novel catalase mutation (a G insertion in exon 2) causes the type B of the Hungarian acatalasemia. Clinica Chimica Acta 2001, 311, 161-3.
  • Karászi É, Jakab K, Homolya L, Szakács G, Holló Zs, Telek B, Kiss A, Rejtő, L, Nahajevszky S, Sarkadi B, Kappelmayer J. Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia. British Journal of Haematology 112: 308-314, 2001
  • Benkő I, Kovács P, Szegedi I, Megyeri A, Kiss A, Balogh E, Oláh É, Kappelmayer J, Kiss C. Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia. Naunyn-Schmiedeberg’s Archives of Pharmacology 363: 499-508, 2001
  • Oláh L, Misz M, Kappelmayer J,  Ajzner É, Csépány T, Fekete I, Bereczki D, Csiba L.  Natural coagulation inhibitor proteins and elements of fibrinolytic system in young patients with cerebral ischemia. Cerebrovascular Diseases 12: 291-297, 2001
  • Kerekes L, Árkossy P, Altorjay I, Huszka M, Kappelmayer J, Tóth P, Szentkereszty Zs, Sápy P. Evaluation of the haemostatic changes and antioxidant capacity of blood in acute and chronic pancreatitis. Hepato-Gastroenterology  48: 1476-1479, 2001
  • Kappelmayer J, Kiss A, Karászi É, Veszprémi A, Jakó J, Kiss C. Identification of P-selectin Glycoprotein Ligand-1 as a useful marker in acute myeloid leukaemias. British Journal of Haematology 115:903-909, 2001
  • Káplár M, Kappelmayer J, Veszrémi A, Szabó K, Udvardy M. The role of in vivo formation of platelet-leukocyte aggregates in the pathogenesis of diabetic angiopathy. Platelets 12: 419-422, 2001

Frissítés dátuma: 2019.06.27.